Table 2 Outcomes of the cost analyses for two groups of patients receiving adsorptive granulocyte and monocyte apheresis (GMA) or prednisolone (PSL) at the end of the study (average values are presented)

Days of hospitalization

41.1

41.8

ns

(n=19)

(n=17)

Hospitalization cost (euro)*

12739.4

8633.6

P<0.05

(n=19)

(n=17)

Cumulative dose of PSL before the treatment (mg)

2457.9

3030.4

ns

(n=24)

(n=17)

Concomitant dose of PSL during this study (mg)

0 (naïve)

1122.4

P<0.001

(n=24)

(n=17)

Cumulative dose of PSL up to the end of study (mg)

2457.9

4152.8

P=0.28

(n=24)

(n=17)

Adverse event (%)

Transient

12.5

11.8

ns

Non-transient

0

35.3

P<0.001